- Home
- CUK vs NTRA Comparison
CUK vs NTRA Comparison
Compare CUK & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUK
- NTRA
- Stock Information
- Founded
- CUK 1972
- NTRA 2003
- Country
- CUK United States
- NTRA United States
- Employees
- CUK N/A
- NTRA N/A
- Industry
- CUK Marine Transportation
- NTRA Medical Specialities
- Sector
- CUK Consumer Discretionary
- NTRA Health Care
- Exchange
- CUK Nasdaq
- NTRA Nasdaq
- Market Cap
- CUK 26.6B
- NTRA 24.9B
- IPO Year
- CUK 2000
- NTRA 2015
- Fundamental
- Price
- CUK $25.26
- NTRA $189.57
- Analyst Decision
- CUK Strong Buy
- NTRA Strong Buy
- Analyst Count
- CUK 18
- NTRA 17
- Target Price
- CUK $33.22
- NTRA $196.24
- AVG Volume (30 Days)
- CUK 1.7M
- NTRA 1.1M
- Earning Date
- CUK 09-29-2025
- NTRA 11-07-2025
- Dividend Yield
- CUK N/A
- NTRA N/A
- EPS Growth
- CUK 61.65
- NTRA N/A
- EPS
- CUK 1.94
- NTRA N/A
- Revenue
- CUK $26,230,000,000.00
- NTRA $1,964,250,000.00
- Revenue This Year
- CUK $9.15
- NTRA $24.17
- Revenue Next Year
- CUK $3.92
- NTRA $15.57
- P/E Ratio
- CUK $14.46
- NTRA N/A
- Revenue Growth
- CUK 7.15
- NTRA 44.38
- 52 Week Low
- CUK $13.65
- NTRA $117.27
- 52 Week High
- CUK $29.80
- NTRA $198.99
- Technical
- Relative Strength Index (RSI)
- CUK 37.57
- NTRA 65.65
- Support Level
- CUK $26.37
- NTRA $183.88
- Resistance Level
- CUK $27.18
- NTRA $198.99
- Average True Range (ATR)
- CUK 0.77
- NTRA 6.31
- MACD
- CUK 0.04
- NTRA 1.30
- Stochastic Oscillator
- CUK 7.30
- NTRA 69.62
About CUK Carnival Plc ADS ADS
Carnival is the largest global cruise company, with more than 90 ships in service at the end of fiscal 2024. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It's currently folding its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.
About NTRA Natera Inc.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.